What documentation is required when a pharmacy discovers a discrepancy in controlled substance inventory?

Practise this MPJE Pharmacy Law Exam Prep question free, then download the PDF, watch the video walkthrough, or unlock timed mock exams for the full web bank.

Download PDF Watch video

Multiple choice — select the best answer

AOnly notification to the wholesaler
BOnly an internal memo to pharmacy staff
COnly adjustment of the inventory records
DDocumentation of the investigation and reporting to DEA on Form 106 for significant losses

✓ Correct answer: D. Documentation of the investigation and reporting to DEA on Form 106 for significant losses When a discrepancy in controlled substance inventory is discovered, pharmacies must document the investigation of the discrepancy, report significant losses to the DEA using Form 106, and maintain records of the incident and resolution.

.q-expl{display:block!important}.q-opt[data-idx="3"]{border-color:#16a34a;background:#f0fdf4}.q-opt[data-idx="3"] .oltr{background:#16a34a;color:#fff}.q-opt{cursor:default!important;pointer-events:none}

Keep practising. Use the free MPJE Pharmacy Law Exam Prep PDF, watch the YouTube walkthrough, or unlock all 10 web questions with timed mock exams.

Free PDF Video walkthrough

← Previous Next → 🎲 Random question ↩ Back to all questions

Keep practising

What documentation is required when a pharmacy discovers a discrepancy in controlled substance inventory?

Related questions

Free practice here. Timed mocks when you are ready.